ARTICLE | Clinical News
SEPA delivery of prostaglandin E1: MCHM started Phase I/II trials
May 20, 1996 7:00 AM UTC
MacroChem Corp. (MCHM), Lexington, Mass. Product: SEPA delivery of prostaglandin E1 Indication: Erectile dysfunction. Status: MCHM started Phase I/II trials of its topical SEPA gel formulation of pros...